跳至主要内容
临床试验/ACTRN12611000149965
ACTRN12611000149965招募中未知

Feasibility of use of acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer

Royal Prince Alfred Hospital0 个研究点目标入组 30 人开始时间: 2011年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Early breast cancer patients taking thrid generaion aromatase inhibitor.
  • Women with ongoing pain and/or stiffness in one or more joints which worsened after starting aromatase inhibitor.
  • Baseline worst pain score on BPI-SF of 3 or greater (scale 0-10)

排除标准

  • Previous use of acupuncture for Aromatase Inhibitor induced joint paint
  • Severe concomitant illness or metastatic breast cancer
  • Severe coagulopathy or bleeding disorder or dermatological disease within the acupuncture area (including patients on warfarin or low molecular weight heparin).
  • Patients with cardiac pacemakers, defibrilator or any other implanted or topical electrical device.
  • Needle phobia rendering a patient unable to receive acupuncture.
  • Patients with intellectual or mental impairment

研究者

相似试验